139 related articles for article (PubMed ID: 19031967)
1. Protective effect of Cox-2 allelic variants on risk of colorectal adenoma development in African Americans.
Ashktorab H; Tsang S; Luke B; Sun Z; Adam-Campbell L; Kwagyan J; Poirier R; Akter S; Akhgar A; Smoot D; Munroe DJ; Ali IU
Anticancer Res; 2008; 28(5B):3119-23. PubMed ID: 19031967
[TBL] [Abstract][Full Text] [Related]
2. Linkage disequilibrium and haplotype analysis of COX-2 and risk of colorectal adenoma development.
Kwagyan J; Apprey V; Ashktorab H
Clin Transl Sci; 2012 Feb; 5(1):60-4. PubMed ID: 22376259
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms in the cyclooxygenase-1 and cyclooxygenase-2 genes and risk of colorectal adenoma.
Gong Z; Bostick RM; Xie D; Hurley TG; Deng Z; Dixon DA; Zhang J; Hebert JR
Int J Colorectal Dis; 2009 Jun; 24(6):647-54. PubMed ID: 19205707
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms of cyclooxygenase-2 and colorectal adenoma risk: the Self Defense Forces Health Study.
Ueda N; Maehara Y; Tajima O; Tabata S; Wakabayashi K; Kono S
Cancer Sci; 2008 Mar; 99(3):576-81. PubMed ID: 18167131
[TBL] [Abstract][Full Text] [Related]
5. Allellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma.
Ali IU; Luke BT; Dean M; Greenwald P
Br J Cancer; 2005 Oct; 93(8):953-9. PubMed ID: 16205694
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trial.
Barry EL; Sansbury LB; Grau MV; Ali IU; Tsang S; Munroe DJ; Ahnen DJ; Sandler RS; Saibil F; Gui J; Bresalier RS; McKeown-Eyssen GE; Burke C; Baron JA
Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2726-33. PubMed ID: 19755647
[TBL] [Abstract][Full Text] [Related]
7. Colorectal adenoma risk is modified by the interplay between polymorphisms in arachidonic acid pathway genes and fish consumption.
Siezen CL; van Leeuwen AI; Kram NR; Luken ME; van Kranen HJ; Kampman E
Carcinogenesis; 2005 Feb; 26(2):449-57. PubMed ID: 15550453
[TBL] [Abstract][Full Text] [Related]
8. Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma.
Peters U; Chatterjee N; Hayes RB; Schoen RE; Wang Y; Chanock SJ; Foster CB
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1144-54. PubMed ID: 18483336
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 overexpression is common in serrated and non-serrated colorectal adenoma, but uncommon in hyperplastic polyp and sessile serrated polyp/adenoma.
Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Glickman JN; Chan AT; Kirkner GJ; Mino-Kenudson M; Fuchs CS; Ogino S
BMC Cancer; 2008 Jan; 8():33. PubMed ID: 18230181
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin H synthase 2 variant (Val511Ala) in African Americans may reduce the risk for colorectal neoplasia.
Lin HJ; Lakkides KM; Keku TO; Reddy ST; Louie AD; Kau IH; Zhou H; Gim JS; Ma HL; Matthies CF; Dai A; Huang HF; Materi AM; Lin JH; Frankl HD; Lee ER; Hardy SI; Herschman HR; Henderson BE; Kolonel LN; Le Marchand L; Garavito RM; Sandler RS; Haile RW; Smith WL
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1305-15. PubMed ID: 12433707
[TBL] [Abstract][Full Text] [Related]
11. Genetic ancestry is associated with colorectal adenomas and adenocarcinomas in Latino populations.
Hernandez-Suarez G; Sanabria MC; Serrano M; Herran OF; Perez J; Plata JL; Zabaleta J; Tenesa A
Eur J Hum Genet; 2014 Oct; 22(10):1208-16. PubMed ID: 24518838
[TBL] [Abstract][Full Text] [Related]
12. The multidrug resistance 1 (MDR1) gene polymorphism G-rs3789243-A is not associated with disease susceptibility in Norwegian patients with colorectal adenoma and colorectal cancer; a case control study.
Andersen V; Agerstjerne L; Jensen D; Østergaard M; Saebø M; Hamfjord J; Kure E; Vogel U
BMC Med Genet; 2009 Feb; 10():18. PubMed ID: 19250544
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants in frizzled-related protein (FRZB) and the risk of colorectal neoplasia.
Berndt SI; Huang WY; Yeager M; Weissfeld JL; Chanock SJ; Hayes RB
Cancer Causes Control; 2009 May; 20(4):487-90. PubMed ID: 19067193
[TBL] [Abstract][Full Text] [Related]
14. Germline variants and advanced colorectal adenomas: adenoma prevention with celecoxib trial genome-wide association study.
Wang J; Carvajal-Carmona LG; Chu JH; Zauber AG; ; Kubo M; Matsuda K; Dunlop M; Houlston RS; Sieber O; Lipton L; Gibbs P; Martin NG; Montgomery GW; Young J; Baird PN; Ratain MJ; Nakamura Y; Weiss ST; Tomlinson I; Bertagnolli MM
Clin Cancer Res; 2013 Dec; 19(23):6430-7. PubMed ID: 24084763
[TBL] [Abstract][Full Text] [Related]
15. Racial differences in the association of insulin-like growth factor pathway and colorectal adenoma risk.
Ochs-Balcom HM; Vaughn CB; Nie J; Chen Z; Thompson CL; Parekh N; Tracy R; Li L
Cancer Causes Control; 2014 Feb; 25(2):161-70. PubMed ID: 24194259
[TBL] [Abstract][Full Text] [Related]
16. Intestinal PTGS2 mRNA levels, PTGS2 gene polymorphisms, and colorectal carcinogenesis.
Vogel LK; Sæbø M; Høyer H; Kopp TI; Vogel U; Godiksen S; Frenzel FB; Hamfjord J; Bowitz-Lothe IM; Johnson E; Kure EH; Andersen V
PLoS One; 2014; 9(8):e105254. PubMed ID: 25166592
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in genes related to inflammation and obesity and colorectal adenoma risk.
Huang BZ; Tsilidis KK; Smith MW; Hoffman-Bolton J; Visvanathan K; Platz EA; Joshu CE
Mol Carcinog; 2018 Oct; 57(10):1278-1288. PubMed ID: 29802748
[TBL] [Abstract][Full Text] [Related]
18. DNA base excision repair genetic risk scores, oxidative balance, and incident, sporadic colorectal adenoma.
Wang T; Goodman M; Sun YV; Thyagarajan B; Gross M; Bostick RM
Mol Carcinog; 2017 Jun; 56(6):1642-1652. PubMed ID: 28120344
[TBL] [Abstract][Full Text] [Related]
19. Variants in the alpha-Methylacyl-CoA racemase gene and the association with advanced distal colorectal adenoma.
Daugherty SE; Platz EA; Shugart YY; Fallin MD; Isaacs WB; Chatterjee N; Welch R; Huang WY; Hayes RB
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1536-42. PubMed ID: 17684125
[TBL] [Abstract][Full Text] [Related]
20. Nucleotide excision repair gene polymorphisms and risk of advanced colorectal adenoma: XPC polymorphisms modify smoking-related risk.
Huang WY; Berndt SI; Kang D; Chatterjee N; Chanock SJ; Yeager M; Welch R; Bresalier RS; Weissfeld JL; Hayes RB
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):306-11. PubMed ID: 16492920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
